Matches in SemOpenAlex for { <https://semopenalex.org/work/W4308440151> ?p ?o ?g. }
Showing items 1 to 86 of
86
with 100 items per page.
- W4308440151 endingPage "459" @default.
- W4308440151 startingPage "454" @default.
- W4308440151 abstract "This study assessed the incidence of mild, moderate and severe adverse events (AEs) and examined their association with age, sex, body region examined, time to event and duration of the AE(s) in a large cohort of patients who underwent contrast-enhanced ultrasound (CEUS) with Lumason/SonoVue. In this retrospective observational study, 49,100 patients who underwent CEUS were analyzed. Forty-three (0.088%) patients experienced AEs, with 23 (0.047%) patients experiencing mild AEs, 13 (0.026%) experiencing moderate AEs and 7 (0.014%) experiencing severe AEs. No fatal event occurred. There was no age- or sex-related difference in the incidence of the AE(s) (p = 0.158 and p = 0.474). Inpatients (0.17%) more often experienced AEs than outpatients (0.06%, p = 0.003). The mean time to event for mild and moderate AEs was 14.50 ± 6.96 and 15.75 ± 10.40 min, respectively, whereas that for severe AEs was 1.89 ± 1.21 min after the injection. The remission time for mild and moderate AEs was approximately 30-40 min, and all patients with severe AEs recovered within 12 h. Twenty-one (48.8%) patients received medical treatment. In summary, Lumason/SonoVue has a good safety profile with a low incidence of AEs, most of which are mild with a short time to event and duration." @default.
- W4308440151 created "2022-11-11" @default.
- W4308440151 creator A5004115989 @default.
- W4308440151 creator A5010752967 @default.
- W4308440151 creator A5028576686 @default.
- W4308440151 creator A5029811844 @default.
- W4308440151 creator A5037409771 @default.
- W4308440151 creator A5044573130 @default.
- W4308440151 creator A5084291242 @default.
- W4308440151 creator A5086664284 @default.
- W4308440151 date "2023-02-01" @default.
- W4308440151 modified "2023-10-14" @default.
- W4308440151 title "Safety Analysis of Adverse Events of Ultrasound Contrast Agent Lumason/SonoVue in 49,100 Patients" @default.
- W4308440151 cites W1950933159 @default.
- W4308440151 cites W1999584733 @default.
- W4308440151 cites W2000355851 @default.
- W4308440151 cites W2042178788 @default.
- W4308440151 cites W2088302753 @default.
- W4308440151 cites W2169502157 @default.
- W4308440151 cites W2309322354 @default.
- W4308440151 cites W2416860113 @default.
- W4308440151 cites W2569746211 @default.
- W4308440151 cites W2908791866 @default.
- W4308440151 cites W2987163158 @default.
- W4308440151 cites W3045466893 @default.
- W4308440151 cites W3089962069 @default.
- W4308440151 doi "https://doi.org/10.1016/j.ultrasmedbio.2022.09.014" @default.
- W4308440151 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36357252" @default.
- W4308440151 hasPublicationYear "2023" @default.
- W4308440151 type Work @default.
- W4308440151 citedByCount "1" @default.
- W4308440151 countsByYear W43084401512023 @default.
- W4308440151 crossrefType "journal-article" @default.
- W4308440151 hasAuthorship W4308440151A5004115989 @default.
- W4308440151 hasAuthorship W4308440151A5010752967 @default.
- W4308440151 hasAuthorship W4308440151A5028576686 @default.
- W4308440151 hasAuthorship W4308440151A5029811844 @default.
- W4308440151 hasAuthorship W4308440151A5037409771 @default.
- W4308440151 hasAuthorship W4308440151A5044573130 @default.
- W4308440151 hasAuthorship W4308440151A5084291242 @default.
- W4308440151 hasAuthorship W4308440151A5086664284 @default.
- W4308440151 hasConcept C120665830 @default.
- W4308440151 hasConcept C121332964 @default.
- W4308440151 hasConcept C126322002 @default.
- W4308440151 hasConcept C126838900 @default.
- W4308440151 hasConcept C141071460 @default.
- W4308440151 hasConcept C143753070 @default.
- W4308440151 hasConcept C167135981 @default.
- W4308440151 hasConcept C197934379 @default.
- W4308440151 hasConcept C61511704 @default.
- W4308440151 hasConcept C71924100 @default.
- W4308440151 hasConcept C72563966 @default.
- W4308440151 hasConceptScore W4308440151C120665830 @default.
- W4308440151 hasConceptScore W4308440151C121332964 @default.
- W4308440151 hasConceptScore W4308440151C126322002 @default.
- W4308440151 hasConceptScore W4308440151C126838900 @default.
- W4308440151 hasConceptScore W4308440151C141071460 @default.
- W4308440151 hasConceptScore W4308440151C143753070 @default.
- W4308440151 hasConceptScore W4308440151C167135981 @default.
- W4308440151 hasConceptScore W4308440151C197934379 @default.
- W4308440151 hasConceptScore W4308440151C61511704 @default.
- W4308440151 hasConceptScore W4308440151C71924100 @default.
- W4308440151 hasConceptScore W4308440151C72563966 @default.
- W4308440151 hasFunder F4320321001 @default.
- W4308440151 hasFunder F4320334977 @default.
- W4308440151 hasIssue "2" @default.
- W4308440151 hasLocation W43084401511 @default.
- W4308440151 hasLocation W43084401512 @default.
- W4308440151 hasOpenAccess W4308440151 @default.
- W4308440151 hasPrimaryLocation W43084401511 @default.
- W4308440151 hasRelatedWork W2003938723 @default.
- W4308440151 hasRelatedWork W2047967234 @default.
- W4308440151 hasRelatedWork W2118496982 @default.
- W4308440151 hasRelatedWork W2275480158 @default.
- W4308440151 hasRelatedWork W2364998975 @default.
- W4308440151 hasRelatedWork W2369162477 @default.
- W4308440151 hasRelatedWork W2439875401 @default.
- W4308440151 hasRelatedWork W2603773853 @default.
- W4308440151 hasRelatedWork W4238867864 @default.
- W4308440151 hasRelatedWork W2525756941 @default.
- W4308440151 hasVolume "49" @default.
- W4308440151 isParatext "false" @default.
- W4308440151 isRetracted "false" @default.
- W4308440151 workType "article" @default.